Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EZETIMIBE\ROSUVASTATIN vs FARICIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EZETIMIBE\ROSUVASTATIN vs FARICIMAB: Safety Overview

Metric	EZETIMIBE\ROSUVASTATIN	FARICIMAB
Total FAERS Reports	329	381
Deaths Reported	14	23
Death Rate	4.3%	6.0%
Hospitalizations	138	98
Average Patient Age	65.8 yrs	69.6 yrs
% Female Patients	26.8%	51.2%
Manufacturer	N/A	Genentech, Inc.
Route	N/A	INTRAVITREAL